Administrative Burden and Costs of Prior Authorizations in a Dermatology Department
Open Access
- 26 August 2020
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Dermatology
- Vol. 156 (10) , 1074-1078
Abstract
Insurance companies use prior authorizations (PAs) to address inappropriate prescribing and unnecessary variations in care, commonly for expensive medications and procedures. However, PAs often delay and sometimes prevent essential and appropriate treatments and are associated with poor patient outcomes.1,2 Prior authorizations add administrative burden to physician offices and appear to be increasing over time.1-5 The American Medical Association has called for PA reform.3Keywords
This publication has 12 references indexed in Scilit:
- Examining the prior authorization process, patient outcomes, and the impact of a pharmacy intervention: A single-center reviewJournal of the American Academy of Dermatology, 2019
- Prior Authorizations for Diagnostic Skin BiopsiesJAMA Dermatology, 2017
- Prior authorizations for dermatologic medications: An American Academy of Dermatology survey of US dermatology providers and staffJournal of the American Academy of Dermatology, 2017
- The state and consequences of dermatology drug prices in the United StatesJournal of the American Academy of Dermatology, 2016
- The effect of omalizumab dosing and frequency in chronic idiopathic urticaria: Retrospective chart reviewJournal of the American Academy of Dermatology, 2016
- Changes in Retail Prices of Prescription Dermatologic Drugs From 2009 to 2015JAMA Dermatology, 2016
- The cost of biologics for psoriasis is increasingDrugs in Context, 2014
- Impact of Prior Authorization Restrictions on Resource Utilization and Costs In US Health Plans: A Review Of LiteratureValue in Health, 2014
- Uncompensated Medical Provider Costs Associated with Prior Authorization for Prescription Medications in an HIV ClinicClinical Infectious Diseases, 2010
- Prior authorization for topical psoriasis treatments: Is it cost-beneficial for managed care?Journal of Dermatological Treatment, 2009